SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Update Passive Stake in Sage Therapeutics to 0.8%
Beneficial Ownership Statement
FMR LLC and Abigail P. Johnson have filed an Amendment No. 16 to their Schedule 13G, disclosing a beneficial ownership of 0.8% of Sage Therapeutics Inc.'s common stock as of February 28, 2025.
Summary
- FMR LLC and Abigail P. Johnson filed an Amendment No. 16 to Schedule 13G regarding their beneficial ownership in SAGE THERAPEUTICS INC.
- As of February 28, 2025, the reporting persons collectively beneficially own 500,915.31 shares of SAGE THERAPEUTICS INC common stock.
- This ownership represents 0.8% of the total class of securities.
- FMR LLC holds sole voting power over 496,435.00 shares and sole dispositive power over 500,915.31 shares.
- Abigail P. Johnson holds sole dispositive power over 500,915.31 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine disclosure of passive beneficial ownership and does not contain performance or strategic information.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of event which requires filing of this statement |
| 03/06/2025 | Date of filing of this statement |
Keywords
SAGE THERAPEUTICS INC, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.